DYNE THERAPEUTICS INC shareholders Q3 2023

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.

DYNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
NORTHERN TRUST CORP 394,251$3,532,4890.00%
GEODE CAPITAL MANAGEMENT, LLC 857,710$7,685,9800.00%
STATE STREET CORP 1,938,642$17,370,2320.00%
STATE OF WISCONSIN INVESTMENT BOARD 21,123$189,2620.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 325,371$2,915,3240.00%
BlackRock Inc. 3,306,965$29,630,4070.00%
Walleye Trading LLC 24,326$217,9610.00%
PUTNAM INVESTMENTS LLC 36,737$329,1640.00%
DekaBank Deutsche Girozentrale 40,000$3520.00%
TWO SIGMA ADVISERS, LP 51,600$462,3360.00%
Ameritas Investment Partners, Inc. 3,510$31,4500.00%
AQR Capital Management 11,644$104,3300.00%
EverSource Wealth Advisors, LLC 90$8060.00%
JANUS HENDERSON GROUP PLC 11,364$101,7100.00%
JPMORGAN CHASE & CO 338,174$3,030,0390.00%
PRICE T ROWE ASSOCIATES INC /MD/ 175,387$1,5720.00%
NEW YORK STATE COMMON RETIREMENT FUND 16,348$1460.00%
Belvedere Trading LLC 16,058$143,8800.00%
NISA INVESTMENT ADVISORS, LLC 35$3140.00%
MARSHALL WACE, LLP 22,052$197,5860.00%
External links

This page lists DYNE THERAPEUTICS INC's shareholders in Q3 2023. To view DYNE THERAPEUTICS INC's shareholder history, click here.